chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: aches; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches) and FATIGUE (tiredness) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced PAIN (aches) and FATIGUE (tiredness). At the time of the report, PAIN (aches) and FATIGUE (tiredness) outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-424570, MOD-2021-424597 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Nervous system disorder, Vaccination complication
Clinical narrative: issues with control/ may die from the vaccine; issues with his nervous system; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (issues with control/ may die from the vaccine) and NERVOUS SYSTEM DISORDER (issues with his nervous system) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (issues with control/ may die from the vaccine) and NERVOUS SYSTEM DISORDER (issues with his nervous system). At the time of the report, VACCINATION COMPLICATION (issues with control/ may die from the vaccine) had not resolved and NERVOUS SYSTEM DISORDER (issues with his nervous system) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Sep-2021 at 11:51 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021) to be not related.    No adverse reaction reported.  Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Hypertensive heart disease, benign (without Congestive heart failure). Concomitant products included BENAZEPRIL for COVID-19 vaccination.    On 17-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.  Past the 30 day beyond use date. Vials were removed from freezer to refrigeration on day of vaccination 03 Sep 2021 and 17 Sep 2021.
Sex: U
Vaccine: COVID19
Symptoms: Tooth disorder
Clinical narrative: dental issues for a couple of months now; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH DISORDER (dental issues for a couple of months now) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOOTH DISORDER (dental issues for a couple of months now). At the time of the report, TOOTH DISORDER (dental issues for a couple of months now) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient was getting the second dose of Moderna on Monday. The patient reported to have a tooth fill later and needs to take antibiotics. Concomitant and treatment medication information was not reported.  information was not reported
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.    On 07-Sep-2021 at 2:47 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021). On 07-Sep-2021, EXPIRED PRODUCT ADMINISTERED (vaccine expired on 08/31/2021 and vaccine was administered on 09/07/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment drugs were reported.  It was reported that patient had not tested positive for COVID-19.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm that is painful, making arms and hands weak and limiting day to day activities; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm that is painful, making arms and hands weak and limiting day to day activities) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041C21A and 026D21A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included GLIPIZIDE, TRIAMTERENE, POTASSIUM, ATORVASTATIN and LISINOPRIL for an unknown indication.   On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Jun-2021, the patient experienced VACCINATION SITE PAIN (sore arm that is painful, making arms and hands weak and limiting day to day activities). At the time of the report, VACCINATION SITE PAIN (sore arm that is painful, making arms and hands weak and limiting day to day activities) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (vaccine expired) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 037A21B) for COVID-19 immunization. No medical history reported. Concomitant products included famotidine for an unknown indication. On Oct 9, 2021, at 1:33 pm, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Oct 9, 2021, patient experienced administered expired product (vaccine expired). On Oct 9, 2021, administered expired product (vaccine expired) resolved. The reporter did not provide any causality assessments. It was reported the patient has no known drug allergy. The patient has no chronic conditions. The patient had no adverse events. No treatment reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Neck pain
Clinical narrative: Pain in her back; Pain in her neck; Pain in both shoulders; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Pain in her back), NECK PAIN (Pain in her neck) and ARTHRALGIA (Pain in both shoulders) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Dec-2021, the patient experienced BACK PAIN (Pain in her back), NECK PAIN (Pain in her neck) and ARTHRALGIA (Pain in both shoulders). At the time of the report, BACK PAIN (Pain in her back), NECK PAIN (Pain in her neck) and ARTHRALGIA (Pain in both shoulders) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by the reporter. No treatment was reported by the reporter.  On 22-Dec-2021, the patient started experiencing pain in back, neck and both shoulders at bedtime. The pain was getting worse and was very bad in the evening.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: he got the vaccine and went down too and now patient  walks in a cane; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (he got the vaccine and went down too and now patient  walks in a cane) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (he got the vaccine and went down too and now patient  walks in a cane). At the time of the report, VACCINATION COMPLICATION (he got the vaccine and went down too and now patient  walks in a cane) outcome was unknown.            Concomitant medication was not reported. Treatment information was not reported.   This case was linked to MOD-2021-425242 (Patient Link).   Reporter did not allow further contact
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, SARS-CoV-2 test
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 15-Jan-2021. Concurrent medical conditions included Type 2 diabetes mellitus, Hypertension, Hyperlipidemia and Obesity. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), LOVASTATIN, METFORMIN and VERAPAMIL for an unknown indication.    On 03-Sep-2021 at 11:32 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021 at 11:32 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 03-Sep-2021 at 11:32 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test: positive (Positive) positive for Rapid Antigen test.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information provided.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Sep-2021 at 4:09 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.) to be not related.    No Concomitant medications were reported.  No treatment medications were reported.  It was reported that this lot number expiration date was not extended.   This case was linked to MOD-2021-328706 (Patient Link).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Sep-2021 at 11:49 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant and treatment drugs were provided.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included Hyperlipidemia. Concurrent medical conditions included Penicillin allergy, Hypertension, COPD and Alcohol abuse. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], SIMVASTATIN, LISINOPRIL, GABAPENTIN and TRAZODONE for an unknown indication.    On 03-Sep-2021 at 2:09 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.   This case was linked to MOD-2021-328706 (Patient Link).
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Polymerase chain reaction
Clinical narrative: Expired vaccine used; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 12-Jan-2021. Concomitant products included METFORMIN, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), ATORVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID] and GLIMEPIRIDE for an unknown indication.    On 03-Sep-2021 at 11:33 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021 at 11:33 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 03-Sep-2021 at 11:33 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Polymerase chain reaction: positive (Positive) positive for COVID-19.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was reported. It was reported that, the patient had no known drug allergy.The patient had no chronic conditions like Diabetes type 2, obesity, PAD and HTN. The patient had no adverse events.  The patient height was 67.5 inches and weight was 316 pounds   This case was linked to MOD-2021-328706 (Patient Link).
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Mixed hyperlipidemia, Type 2 diabetes mellitus, Obesity and Drug allergy (allergy to codeine). Concomitant products included LISINOPRIL, METFORMIN, ACETYLSALICYLIC ACID (ASPIRINE), SIMVASTATIN and INSULIN DETEMIR (LEVEMIR) for an unknown indication.    On 17-Sep-2021 at 4:34 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 09/17/2021.) to be not related.    There was no adverse reaction. Patient height reported as 65 inches.   No treatment medications were provided.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concomitant products included FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE (TRELEGY ELLIPTA), SALBUTAMOL SULFATE (PROAIR HFA), ATORVASTATIN and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 03-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided by the reporter.   This case was linked to MOD-2021-328706 (Patient Link).
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, SARS-CoV-2 test positive
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 07-Sep-2021, Depression and Obesity. Concurrent medical conditions included GERD. Concomitant products included OMEPRAZOLE for an unknown indication.    On 17-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, SARS-CoV-2 test positive: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 17-sep-2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 17-sep-2021) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension NOS and Hypothyroidism.    On 17-Sep-2021 at 4:04 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 17-sep-2021). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 17-sep-2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on 17-sep-2021) to be not related.    NO Concomitant & Treatment drug reported
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Sep-2021 at 4:07 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) to be not related.    No concomitant medication and treatment information provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine expired on 08/31/2021 and vaccine was administered on 09/03/2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/03/2021) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus, Hypertension, Smoker and Alcohol abuse. Concomitant products included METFORMIN and HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) for an unknown indication.    On 03-Sep-2021 at 11:36 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021 at 11:36 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/03/2021). On 03-Sep-2021 at 11:36 AM, EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/03/2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (Vaccine expired on 08/31/2021 and vaccine was administered on 09/03/2021) to be not related.    No treatment medication were reported.  It was reported that there was no adverse reaction and the lot number expiration date was not extended.   This case was linked to MOD-2021-328706 (Patient Link).
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (sulfa), Vitamin D deficiency, Depression, Obesity, Anxiety and Migraine. Concomitant products included BUSPIRONE, ESCITALOPRAM, FAMOTIDINE, ATORVASTATIN and CYPROHEPTADINE for an unknown indication.    On 17-Sep-2021 at 4:31 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021 at 4:31 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 17-Sep-2021 at 4:31 PM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) to be not related.    There was no adverse reaction.   There was no acute illnesses at the time of vaccination and up to one month before. No treatment drug was reported.   This case was linked to MOD-2021-328706 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Would you like to know my side effects from the vaccine/Yes; This spontaneous case was reported by another health care professional and describes the occurrence of VACCINATION COMPLICATION (Would you like to know my side effects from the vaccine/Yes) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Dec-2021, the patient experienced VACCINATION COMPLICATION (Would you like to know my side effects from the vaccine/Yes). At the time of the report, VACCINATION COMPLICATION (Would you like to know my side effects from the vaccine/Yes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: booster injection sore; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE PAIN (booster injection sore) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced VACCINATION SITE PAIN (booster injection sore). At the time of the report, VACCINATION SITE PAIN (booster injection sore) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The patient reported that their booster injection sore has never healed and they got it six weeks ago.  No treatment information was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 038B21A and 038B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Drug allergy (Sulfa), Drug allergy (Erythromycin) and Allergy (Serious allergy to food, a vaccine component or latex).   On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-424036 (Patient Link).
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Hepatic enzyme abnormal, Libido decreased
Clinical narrative: Administered expired doses of the Moderna COVID-19 vaccine; This spontaneous case was reported by another health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired doses of the Moderna COVID-19 vaccine) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 003B21A and 003B21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: Influenza (INFLUENZA, Series 1 and 10/18/2019). Past adverse reactions to the above products included No adverse event with Influenza. Concurrent medical conditions included Snoring, Long QT syndrome, Allergic rhinitis, Seasonal allergy, Prostate cancer, Colon cancer, Lung cancer, Hypertension, Hyperlipidemia, GERD and Coronary artery disease. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Adverse event, AZELASTINE HCL for Allergy, LOSARTAN POTASSIUM, UBIDECARENONE (COQ10 [UBIDECARENONE]), VITAMIN C [ASCORBIC ACID], VITAMIN E NOS, CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and CYANOCOBALAMIN (VITAMIN B-12) for an unknown indication.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired doses of the Moderna COVID-19 vaccine). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired doses of the Moderna COVID-19 vaccine) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme abnormal: abnormal (abnormal) abnormal. On an unknown date, Libido decreased: decreased (Low) Decreased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Lab exam (ICD-V72.6) (ICD10-Z01.89) Sereen Shin Cancer (ICD-V76.43) (ICD10-Z12.83) Physical exam, routine (ICD-V70.0) (ICD10-Z00.00) Reported stated-Eye fillers Reporter stated, INFLUENZA, Series 1, 10/18/2019 INFLUENZA, Series 2, 9/25/2020 INFLUENZA, Series 3, 10/18/2021
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 003B21A and 003B21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: influenza. Past adverse reactions to the above products included No adverse event with influenza. Concurrent medical conditions included Hyperlipidemia, Mood disorder (Mood disorder of depressed type), Anxiety, Depression, Androgens increased, Cervical cancer, Cough, Acne vulgaris, Ovarian cancer, Osteoporosis, Breast cancer, Lung cancer, Skin cancer and Colon cancer. Concomitant products included SPIRONOLACTONE for Acne, METOPROLOL TARTRATE, BUPROPION HYDROCHLORIDE (BUPROPION HCL ER), BUPROPION HCL, VITAMIN D3, ASCORBIC ACID (VITAMIN C ACID), NICOTINAMIDE, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMIN-B COMPLEX) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient has Reactive airway disease problem. Lab exam  and physical exam  routine. Fish oil 1000 mg oral capsule orally once a day patient was taking. No treatment information provided.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: More than 24 hours after first puncture.; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (More than 24 hours after first puncture.) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032H21A, 031B21A and 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (More than 24 hours after first puncture.). On 23-Dec-2021, EXPIRED PRODUCT ADMINISTERED (More than 24 hours after first puncture.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter. Neither of the patients had reported any symptoms.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (needs a nuclear stress test after 1st dose) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vaccination complication (needs a nuclear stress test after 1st dose). At the time of the report, vaccination complication (needs a nuclear stress test after 1st dose) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included Smoker. Concurrent medical conditions included Diabetes, Hypertension and Hypercholesterolemia. Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET), INSULIN GLARGINE (BASAGLAR), AMLODIPINE and LOVASTATIN for an unknown indication.    On 17-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on). On 17-Sep-2021, EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered EXPIRED PRODUCT ADMINISTERED (There was no adverse reaction, vaccine expired on 08/31/2021 and vaccine was administered on) to be not related.    Treatment details were not given.
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A, 029L20A and 038B21A) for COVID-19 vaccination.     The patient's past medical history included Abdominal pain (right upper quadrant), Pharyngitis, Sprain of lateral collateral ligament of knee (collateral ligament instability, right knee), Prostate cancer, Skin cancer, Lung cancer and Colon cancer. Concurrent medical conditions included Peripheral neuropathy (arm, left arm/elbow post vaccine injection), Groin pain (right), Vitamin D deficiency, Gout (right great toe), Meniscus tear of knee (right knee), Glucose intolerance, Unspecified disorder of autonomic nervous system, Seasonal allergy and Atrial fibrillation. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, COLCHICINE (COLCRYS) for Gout, ZOLPIDEM TARTRATE (AMBIEN) for Sleep disorder, BERBERINE CHLORIDE, COLECALCIFEROL, MENAQUINONE-7 (VITAMIN K2 + D3 [COLECALCIFEROL;MENAQUINONE-7]), ACETYLSALICYLIC ACID (ASPIRIN LOW), TART CHERRY and METHYLPREDNISOLONE ACETATE (MEDROL [METHYLPREDNISOLONE ACETATE]) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was reported.  Patient has routine physical exam, lab exam and observation and evaluation for suspected exposure to other biological agent.
Sex: U
Vaccine: COVID19
Symptoms: Product colour issue, Product contamination, Vaccination site mass, Vaccination site swelling
Clinical narrative: Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered; Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered; Injection area swelled up; Little bubble in the injection area; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT COLOUR ISSUE (Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered), PRODUCT CONTAMINATION (Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered), VACCINATION SITE SWELLING (Injection area swelled up) and VACCINATION SITE MASS (Little bubble in the injection area) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Dec-2021, the patient experienced PRODUCT COLOUR ISSUE (Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered), PRODUCT CONTAMINATION (Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered), VACCINATION SITE SWELLING (Injection area swelled up) and VACCINATION SITE MASS (Little bubble in the injection area). At the time of the report, PRODUCT COLOUR ISSUE (Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered), PRODUCT CONTAMINATION (Vaccine with different color administered/opaque vaccine administered/yellowish vaccine administered), VACCINATION SITE SWELLING (Injection area swelled up) and VACCINATION SITE MASS (Little bubble in the injection area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the color of the vials that they received were different than usual. The reporter mentioned that the color was not white, but opaquer and more yellowish. It was also reported that color was not only seen in the vial, but in the product inside as well. It was further mentioned that when the vaccine poured into a syringe, the color of the vaccine looked normal inside the syringe, and that the discoloration was only seen in the vial.  No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain, Vaccination site pain
Clinical narrative: experiencing extreme pain; soreness in the arm that was injected; feel extremely tired; This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN (experiencing extreme pain), VACCINATION SITE PAIN (soreness in the arm that was injected) and FATIGUE (feel extremely tired) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced PAIN (experiencing extreme pain), VACCINATION SITE PAIN (soreness in the arm that was injected) and FATIGUE (feel extremely tired). At the time of the report, PAIN (experiencing extreme pain), VACCINATION SITE PAIN (soreness in the arm that was injected) and FATIGUE (feel extremely tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.